PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for June 3, 2009 Subscribe to this News Feed    
 

Matawan NJ Chiropractor Offers Back Pain Relief with Decompression Therapy

The Lordex Spine Institute has announced the selection of Dr. Richard Therkelsen in Old Bridge/Matawan to an elite group of specialists offering Spinal Decompression Therapy (SDT), a non-surgical treatment for low back pain. The Lordex Spine System is a revolutionary, non-invasive, non-surgical procedure developed as a solution to the common causes of mechanical spinal pathology including herniated disc, degenerative disc disease, facet syndrome, sciatica, stenosis, and other conditions.

Matawan, NJ (PRWEB) June 3, 2009 -- The Lordex Spine Institute has announced the selection of Dr. Richard Therkelsen in Old Bridge/Matawan to an elite group of specialists offering Spinal Decompression Therapy (SDT), a non-surgical treatment for low back pain. Under the direction of Dr. Therkelsen, the Central Jersey Lordex Spine Institute now offers a solution to the common causes of mechanical spinal pathology including herniated disc, degenerative disc disease, facet syndrome, sciatica, stenosis, and other conditions. "Treatment of lumbar dysfunction," says Dr. Therkelsen "involves more than just pain relief. Restoring proper function by decompressing the disc and stabilizing the spine with strength training is essential for proper treatment. This is what I found the Lordex System offers." The Strength Restoration System (SRS) and Stretch-Flex Techniques (SFT) are integral parts of the Lordex procedure. "Without them, simple decompression is quite temporary. There needs to be a strengthening system in place to stailize the correction that is provided by the decompression. This is what provides long-lasting results", said Dr. Therkelsen.

The Lordex Spine System is a revolutionary, non-invasive, non-surgical procedure developed after many years of research and clinical tests. The system has treated thousands of patients, and has produced an incredible success rate for patients with disc problems. Patients in both acute and chronic pain are potential candidates for the Lordex protocol. Persons with fractures, tumors, infections, or metabolic diseases do not qualify for this procedure.

Eight out of ten Americans suffer from back pain, accounting for 40% of all lost workdays and representing the largest component of worker's compensation. Patients seeking relief spend $25 billion annually. A significant portion of those dollars is spent on medications that only provide temporary relief and do not cure anything. In fact, medications known as NSAIDS (e.g., Celebrex, Tylenol Arthritis Formula) sometimes do more harm than good, often causing liver and kidney problems. "The Lordex System is not only safe and effective," says Dr. Therkelsen, "but painless, which is important to most patients."

For more information Dr. Therkelsen can be reached at 732-290-8950 or visit www.lordexnj.com

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/U3F1YS1IYWxmLUNyYXMtQ3Jhcy1IYWxmLUNvdXAtWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Richard Therkelsen, DC
Central Jersey Lordex Spine Institute
7322908950
Email us Here
Richard Therkelsen
Central Jersey Lordex Spine Institute
7322908950
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move